Apogee Therapeutics (APGE)

• Market cap: $3.81B
• 1 day: -0.05%
• 5 days: 4.8%
• 1 month: 41.48%
• 3 months: 48.56%
• 6 months: 49.15%
• Year to date: 19.51%
• 1 year: 0.04%
• 5 years: 165.43%
• 10 years: 165.43%
• Sector: Healthcare
• Industry: Biotechnology

About: Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Employees: 196